Company intelligence / Profile preview

Jiangsu Shindery Pharmatech

Lianyungang, Jiangsu Province, Chinaxdrpharm.com ↗

Ownership: Private
Development stage: Commercial

Overview

The company specializes in the R&D, production, and sales of nucleic acid drug raw materials and anti-cancer active pharmaceutical ingredients. It has established strategic partnerships with academic institutions for innovation but does not appear to have its own clinical-stage therapeutic pipeline.

Therapeutic areas: Oncology
Modalities: Small molecule (API, anti-cancer drugs)Nucleic acid drug raw materials (Nucleic acid-based therapy components)
Industry: Contract Manufacturing Organization

Partnerships

Nanjing University of Technology and ScienceJiangsu Ocean University

Beyond the preview

Go deeper on Jiangsu Shindery Pharmatech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jiangsu Shindery Pharmatech.

Explore the full profile